August 07, 2025

Every 1,000 Steps May Slash Heart Risk 17%

Each additional 1,000 daily steps a day may be associated with a reduction in major adverse cardiovascular events among patients with hypertension, with benefits evident at step counts well below 10,000 steps per day.

Conexiant

August 07, 2025

Delayed Hypertension Diagnoses Raise 5-Year Cardiovascular Risk

Analysis of electronic health records reveals that delays in clinical hypertension diagnosis persist despite frequent outpatient visits and are linked to increased cardiovascular event rates.

Conexiant

August 07, 2025

Allogeneic Islet Transplant Shows Promise Without Immunosuppression

First-in-human trial shows genetically engineered islet cells restore insulin secretion in type 1 diabetes without triggering immune rejection.

Conexiant

August 07, 2025

Laser-Induced Polymer Fragmentation in IOLs

Nd:YAG lasers are powerful tools — but let’s use them like surgeons, not like Terminators

The Ophthalmologist

August 06, 2025

DASH4D: Sodium Reduction Lowered Blood Pressure in T2D

Researchers found that a lower sodium DASH-style diet tailored for type 2 diabetes reduced blood pressure in adults receiving antihypertensive treatment.

Conexiant

August 06, 2025

Bimekizumab Sustains Psoriasis Response for 3 Years

A 3-year analysis of a phase IIIb trial found that bimekizumab, a dual interleukin-17A and interleukin-17F inhibitor, maintained high rates of skin clearance and demonstrated a consistent safety profile in patients with moderate-to-severe plaque psoriasis, including those who switched from secukinumab, an interleukin-17A inhibitor.

Conexiant

August 06, 2025

Do Retail Health Kiosks Tell Different Story?

Analysis of U.S. retail health kiosk users reveals that nearly half had high blood pressure, with the highest prevalence among non-Hispanic Black adults.

Conexiant

July 30, 2025

JAK Inhibitors May Improve Artery Health Markers

JAK inhibitor therapy targets inflammation and correlates with improvements in carotid artery measurements, while baseline vascular markers continue to predict cardiovascular risk.

Conexiant

August 05, 2025

Weight Regain Persists After Anti-Obesity Treatment

A new meta-analysis of 11 randomized controlled trials found that patients began regaining weight as early as 8 weeks after discontinuing anti-obesity medications, with weight gain continuing through 52 weeks.

Conexiant